IGF1R and non-small cell lung carcinoma: Taken together, the results presented indicate that in NSCLC cells with a high IR:IGF1R ratio the IR contributes to driving tumour cell proliferation and that a small molecule IR/IGF1R inhibitor is a more effective approach to inhibiting cell proliferation.